India to Brazil: Bortezomib Export Trade Route
India has recorded 58 verified shipments of Bortezomib exported to Brazil, representing a combined trade value of $6.2M USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $106.6K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 68% of total export value with 24 shipments worth $4.2M USD. On the buying side, SUN FARMACUTICA DO BRASIL LTDA, is the largest importer in Brazil with $1.5M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , DR REDDYS LABORATORIES LIMITED — together control 96% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Bortezomib corridor is one of India's established pharmaceutical export routes, with 58 shipments documented worth a combined $6.2M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 68% of all export value, reflecting the consolidated nature of India's bortezomib manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $106.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with bortezomib's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 26.8%, placing it at rank #11 among India's top bortezomib export destinations globally.
On the import side, key buyers of Indian bortezomib in Brazil include SUN FARMACUTICA DO BRASIL LTDA,, SUN FARMACUTICA DO BRASIL LTDA , SUN FARMACUTICA DO BRASIL LIMITEDA and 22 others. SUN FARMACUTICA DO BRASIL LTDA, is the single largest importer with 1 shipments valued at $1.5M USD.
Route Characteristics
- Average transit18 days
- Peak seasonQ4
- Primary modeSea freight
- Top portHYDERABAD ACC (INHYD4)
Market Position
- Global rank#11
- Annual growth+26.8%
- Demand growth+22.5%
- Regulatory ease77/100
Top 10 Indian Bortezomib Exporters to Brazil
Showing top 10 of 12 Indian suppliers exporting Bortezomib to Brazil, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $175.9K per shipment | 24 | $4.2M | 68.3% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $237.8K per shipment | 6 | $1.4M | 23.1% |
| 3 | DR REDDYS LABORATORIES LIMITED Avg $137.2K per shipment | 2 | $274.4K | 4.4% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $49.6K per shipment | 2 | $99.3K | 1.6% |
| 5 | DR REDDY S LABORATORIES LIMITED Avg $62.8K per shipment | 1 | $62.8K | 1.0% |
| 6 | MYLAN LABORATORIES LIMITED Avg $56.0K per shipment | 1 | $56.0K | 0.9% |
| 7 | RELIANCE LIFE SCIENCES PRIVATE LIMITED Avg $12.1K per shipment | 2 | $24.2K | 0.4% |
| 8 | MYLAN LABORATORIES LIMITED Avg $11.2K per shipment | 1 | $11.2K | 0.2% |
| 9 | MSN LABORATORIES PRIVATE LIMITED Avg $922 per shipment | 7 | $6.5K | 0.1% |
| 10 | HETERO LABS LIMITED Avg $3 per shipment | 7 | $18 | 0.0% |
This table shows the top 10 of 12 Indian companies exporting bortezomib to Brazil, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , DR REDDYS LABORATORIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, DR REDDY S LABORATORIES LIMITED, MYLAN LABORATORIES LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED, MYLAN LABORATORIES LIMITED , MSN LABORATORIES PRIVATE LIMITED, HETERO LABS LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 24 shipments worth $4.2M USD, giving it a 68% market share. The top 3 suppliers together account for 96% of the total trade value on this route.
Showing top 10 of 12 total Indian exporters on the India to Brazil Bortezomib export route.
Top 10 Bortezomib Importers in Brazil
Showing top 10 of 25 known buyers in Brazil receiving Bortezomib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian bortezomib in Brazil include SUN FARMACUTICA DO BRASIL LTDA,, SUN FARMACUTICA DO BRASIL LTDA , SUN FARMACUTICA DO BRASIL LIMITEDA, SUN FARMACEUTICA DO BRAZIL LTDA., M/S. SUN FARMACEUTICA DO BRAZIL LTD, among 25 total buyers. The largest importer is SUN FARMACUTICA DO BRASIL LTDA,, accounting for $1.5M USD across 1 shipments — representing 24% of all bortezomib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN FARMACUTICA DO BRASIL LTDA, | 1 | $1.5M | 24.2% |
| 2 | SUN FARMACUTICA DO BRASIL LTDA | 4 | $1.1M | 18.6% |
| 3 | SUN FARMACUTICA DO BRASIL LIMITEDA | 3 | $1.0M | 16.5% |
| 4 | SUN FARMACEUTICA DO BRAZIL LTDA. | 2 | $584.3K | 9.5% |
| 5 | M/S. SUN FARMACEUTICA DO BRAZIL LTD | 4 | $385.4K | 6.2% |
| 6 | SUN FARMACEUTICA DO BRAZIL LIMITEDA | 4 | $325.6K | 5.3% |
| 7 | SUN FARMACEUTICA DO BRASIL LTDA | 6 | $310.2K | 5.0% |
| 8 | DR REDDYS FARMACEUTICA DO BRASIL LTDA | 1 | $211.7K | 3.4% |
| 9 | SUN PHARMACEUTICA DO BRASIL LTDA | 1 | $164.2K | 2.7% |
| 10 | SUN FARMACEUTICA DO BRAZIL LTDA | 1 | $112.9K | 1.8% |
Showing top 10 of 25 Bortezomib importers in Brazil on this route.
Top 10 Bortezomib Formulations Imported by Brazil
Showing top 10 of 43 product formulations shipped on the India to Brazil Bortezomib route, ranked by trade value
Brazil imports a wide range of bortezomib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ZOMI EACH CONTAINS BORTEZOMIB,BN-HAE0029 — accounts for $1.5M USD across 1 shipments. There are 43 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ZOMI EACH CONTAINS BORTEZOMIB,BN-HAE0029 | 1 | $1.5M | 24.2% |
| 2 | ZOMI EACH CONTAINS BORTEZOMIB PACK : 01* | 3 | $801.3K | 13.0% |
| 3 | BORTEZOMIB FOR INJECTION 3.5 MG/VIAL. BO | 3 | $620.4K | 10.0% |
| 4 | ZOMI EACH CONTAINS BORTEZOMIB BATCH : H | 1 | $542.7K | 8.8% |
| 5 | BORTEZOMIB FOR INJECTION 3.5 MG VIAL. BO | 2 | $478.3K | 7.7% |
| 6 | ZOMI EACH CONTAINS BORTEZOMIB PACK : 01 | 1 | $425.0K | 6.9% |
| 7 | BORTEZOMIBE | 3 | $337.2K | 5.5% |
| 8 | ZOMI EACH CONTAINS BORTEZOMIB PACK : 01*01 Batch No. As Per DOCUMENT | 3 | $269.9K | 4.4% |
| 9 | BORTEZOMIB FOR INJECTION 3.5 MG/VIAL BORTEZOMIB PAC:01*01 BATCH:HAE2826BPCS | 1 | $178.1K | 2.9% |
| 10 | ZOMI EACH CONTAINS BORTEZOMIB PACK: 01*0 | 1 | $164.2K | 2.7% |
Showing top 10 of 43 Bortezomib formulations imported by Brazil on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 75%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD ACC (INHYD4) handles the highest volume with 10 shipments. Transit time averages 18 days by sea.
Market Dynamics
India's bortezomib exports to Brazil are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 24 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , DR REDDYS LABORATORIES LIMITED — together account for 96% of total trade value on this route. The average shipment value of $106.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as zomi each contains bortezomib pack : 01* and bortezomib for injection 3.5 mg/vial. bo , suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SUN FARMACUTICA DO BRASIL LTDA, is the largest importer with 1 shipments worth $1.5M USD — representing 24% of all bortezomib imports from India on this route. A total of 25 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $6.2M
- Avg. Shipment
- $106.6K
- Suppliers
- 12
- Buyers
- 25
- Transit (Sea)
- ~18 days
- Annual Growth
- +26.8%
Related Analysis
Reverse Direction
Brazil → India — Bortezomib (Import)Other Bortezomib Routes
Unlock the Full India to Brazil Bortezomib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 58 shipments on this route.
Frequently Asked Questions — India to Brazil Bortezomib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Bortezomib to Brazil?
The leading Indian exporters of Bortezomib to Brazil are SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , DR REDDYS LABORATORIES LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 68% of total trade value on this route.
Q What is the total value of Bortezomib exports from India to Brazil?
India exports Bortezomib to Brazil worth approximately $6.2M USD across 58 recorded shipments. The average value per shipment is $106.6K USD.
Q Which ports does India use to ship Bortezomib to Brazil?
The most active port of origin is HYDERABAD ACC (INHYD4) with 10 shipments. Indian exporters primarily use sea freight for this route, with 75% of shipments going by sea and 22% by air.
Q How long does shipping take from India to Brazil for Bortezomib?
The average transit time for Bortezomib shipments from India to Brazil is approximately 18 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Brazil Bortezomib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 26.8% with demand growth tracking at 22.5%. The route is ranked #11 among India's top Bortezomib export destinations globally.
Q How many suppliers are active on the India to Brazil Bortezomib route?
There are currently 12 active Indian suppliers exporting Bortezomib to Brazil. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 68% of total shipment value.
Q Who are the main importers of Bortezomib from India in Brazil?
The leading importers of Indian Bortezomib in Brazil include SUN FARMACUTICA DO BRASIL LTDA,, SUN FARMACUTICA DO BRASIL LTDA , SUN FARMACUTICA DO BRASIL LIMITEDA, SUN FARMACEUTICA DO BRAZIL LTDA., M/S. SUN FARMACEUTICA DO BRAZIL LTD. SUN FARMACUTICA DO BRASIL LTDA, is the largest buyer with 1 shipments worth $1.5M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Brazil export trade corridor identified from Indian Customs (DGFT) records for Bortezomib.
- 2.Supplier/Buyer Matching: 12 Indian exporters and 25 importers in Brazil matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 58 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
58 Verified Shipments
12 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists